Pharmaceuticals

Teva Pharmaceuticals settles with Oklahoma for $85 million in opioid case

Key Points
  • One of the drugmakers in Oklahoma's lawsuit over the opioid crisis agrees to pay the state $85 million.
  • Israeli-owned Teva Pharmaceuticals and Oklahoma Attorney General Mike Hunter announce the settlement Sunday in separate statements.
  • Teva does not admit any wrongdoing under the settlement.
Boxes of tablets, produced by Teva Pharmaceutical Industries.
Chris Ratcliffe | Bloomberg | Getty Images

One of the drugmakers named in Oklahoma's lawsuit over the opioid crisis has agreed to a settlement in which it will pay the state $85 million.

Israeli-owned Teva Pharmaceuticals and Oklahoma Attorney General Mike Hunter announced the settlement Sunday in separate statements. Teva and its related affiliates and Johnson & Johnson and several of its subsidiaries were set to go to trial Tuesday in Norman, Oklahoma.

Hunter said the case against Johnson & Johnson will proceed on schedule.

He also said the funds from the settlement with Teva will be used to fight the opioid crisis in Oklahoma.

Teva did not admit any wrongdoing under the settlement.

Earlier this year, Oklahoma settled with OxyContin maker Purdue Pharma for $270 million.